Increased plasma DYRK1A with aging may protect against neurodegenerative diseases

Archive ouverte

Delabar, Jean, M | Lagarde, Julien | Fructuoso, Marta | Mohammad, Ammara | Bottlaender, Michel | Doran, Eric | Lott, Ira | Rivals, Isabelle | Schmitt, Frederic, A | Head, Elizabeth | Sarazin, Marie | Potier, Marie-Claude

Edité par CCSD ; Nature Pub. Group -

International audience. Early markers are needed for more effective prevention of Alzheimer’s disease. We previously showed that individuals with Alzheimer’s disease have decreased plasma DYRK1A levels compared to controls. We assessed DYRK1A in the plasma of cognitively healthy elderly volunteers, individuals with either Alzheimer’s disease (AD), tauopathies or Down syndrome (DS), and in lymphoblastoids from individuals with DS. DYRK1A levels were inversely correlated with brain amyloid β burden in asymptomatic elderly individuals and AD patients. Low DYRK1A levels were also detected in patients with tauopathies. Individuals with DS had higher DYRK1A levels than controls, although levels were lower in individuals with DS and with dementia. These data suggest that plasma DYRK1A levels could be used for early detection of at risk individuals of AD and for early detection of AD. We hypothesize that lack of increase of DYRK1A at middle age (40–50 years) could be a warning before the cognitive decline, reflecting increased risk for AD.

Suggestions

Du même auteur

Altered age‐linked regulation of plasma DYRK1A in elderly cognitive complainers (INSIGHT‐preAD study) with high brain amyloid load

Archive ouverte | Delabar, Jean, M | CCSD

International audience. Introduction: An effective therapy has not yet been developed for Alzheimer's disease (AD), in part because pathological changes occur years before clinical symptoms manifest. We recently sho...

Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes

Archive ouverte | Cossec, Jack-Christophe | CCSD

International audience. Enlarged early endosomes have been observed in neurons and fibroblasts in Down syndrome (DS). These endosome abnormalities have been implicated in the early development of Alzheimer's disease...

Modifications of the endosomal compartment in fibroblasts from sporadic Alzheimer’s disease patients are associated with cognitive impairment

Archive ouverte | Xicota, Laura | CCSD

International audience. Abstract Morphological alterations of the endosomal compartment have been widely described in post-mortem brains from Alzheimer’s disease (AD) patients and subjects with Down syndrome (DS) wh...

Chargement des enrichissements...